Fosaprepitant 150 mg: Clinical Trials

1 trial of Fosaprepitant 150 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Fosaprepitant 150 mg: new trials by email Literature Review of Fosaprepitant 150 mg trials Research Report on Fosaprepitant 150 mg

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia
Fosaprepitant 150 mg - Postoperative Nausea
Phase 4CompletedStanford University112018-01-012022-07-18

Conditions studied

Postoperative Nausea and Vomiting (1)

Sponsors

Stanford University (1)

Countries

United States (1)

Top investigators

Mark A Burbridge, MD (1)